• to reduced the potential risk of really serious cardiovascular (heart and blood vessel) challenges in Older people with style 2 diabetes and cardiovascular diseaseIn October 2024, Novo Nordisk published a study on scientific journal Nature a couple of novel glucose-delicate insulin NNC2215 that will reduce the risk of hypoglycemia in animal pro